Mesabi Trust (MSB)
(Delayed Data from NYSE)
$16.63 USD
+0.55 (3.42%)
Updated May 1, 2024 04:00 PM ET
After-Market: $16.57 -0.06 (-0.36%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
MSB 16.63 +0.55(3.42%)
Will MSB be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for MSB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for MSB
Mesoblast Shareholder Voting Power Shifts
Mesoblast Advances FDA Approval Process
Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2024
Mesoblast Appoints New Chair Amid Growth Phase
Cash Dividend On The Way From Mesabi Trust (MSB)